| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $670.6M | — | +13.5% |
| Cost of Revenue | $87.5M | — | +5.8% |
| Gross Profit | $583.1M | — | +14.7% |
| R&D Expense | $187.5M | — | +7.8% |
| SG&A Expense | $61.1M | — | +13.7% |
| Operating Income | $49.3M | — | +81.0% |
| Pre-tax Income | $65.6M | — | +78.1% |
| Income Tax | $3.5M | — | -49.6% |
| Net Income | $62.1M | — | +107.5% |
| EPS (Basic) | $0.23 | — | +109.1% |
| EPS (Diluted) | $0.21 | — | +110.0% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $780.4M | +1.4% | +8.9% |
| Accounts Receivable | $335.9M | -0.6% | +69.2% |
| Current Assets | $2.64B | +1.9% | +73.2% |
| Total Assets | $3.32B | +1.2% | +52.4% |
| Current Liabilities | $1.40B | -1.0% | +14.7% |
| Total Liabilities | $3.99B |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $196.8M | — | +21.7% |
| Capital Expenditures | $22.3M | — | +127.0% |
| Investing Cash Flow | -$74.5M | — | -164.4% |
| Financing Cash Flow | -$111.4M | — | -54.2% |
| Free Cash Flow | $174.5M | — | +14.9% |
| +39.3% |
| Stockholders' Equity | -$668.6M | +3.7% | +2.4% |